2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
88
Colonic Neoplasms
30
Colonic Polyps
20
Adenoma
19
Polyps
8
Neoplasms
8
Colorectal Neoplasms, Hereditary Nonpolyposis
6
Adenomatous Polyps
6
Disease
5
Rectal Neoplasms
4
Pain
4
Gastrointestinal Neoplasms
4
Stomach Neoplasms
2
Peptic Ulcer
2
Pancreatic Neoplasms
2
Liver Cirrhosis
2
Intestinal Neoplasms
2
Intestinal Diseases
2
Inflammatory Bowel Diseases
2
Gastritis, Atrophic
2
Digestive System Diseases
2
Colitis, Ulcerative
2
Anus Neoplasms
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Tuberculosis
1
Triple Negative Breast Neoplasms
1
Signs and Symptoms, Digestive
1
Recurrence
1
Rectal Diseases
1
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Observation
3
Neoadjuvant Therapy
3
Epirubicin
3
Endoscopy
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Monatide (IMS 3015)
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Colonoscopy
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled